Motus GI Holdings Inc (NASDAQ:MOTS) – Equities researchers at Oppenheimer issued their Q1 2018 EPS estimates for Motus GI in a research note issued to investors on Monday. Oppenheimer analyst S. Lichtman forecasts that the company will post earnings per share of ($0.24) for the quarter. Oppenheimer currently has a “Outperform” rating and a $7.00 target price on the stock. Oppenheimer also issued estimates for Motus GI’s Q2 2018 earnings at ($0.30) EPS, Q3 2018 earnings at ($0.19) EPS, Q4 2018 earnings at ($0.20) EPS, FY2018 earnings at ($0.93) EPS, FY2019 earnings at ($0.96) EPS, FY2020 earnings at ($0.83) EPS and FY2021 earnings at ($0.40) EPS.
Separately, Piper Jaffray Companies began coverage on Motus GI in a research report on Sunday. They issued an “overweight” rating and a $7.00 target price for the company.
In related news, Chairman David P. Hochman acquired 115,000 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was acquired at an average price of $5.00 per share, for a total transaction of $575,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Mark Pomeranz acquired 8,000 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was bought at an average price of $5.00 per share, with a total value of $40,000.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 1,175,000 shares of company stock valued at $5,875,000.
TRADEMARK VIOLATION WARNING: This report was originally published by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/03/14/analysts-issue-forecasts-for-motus-gi-holdings-incs-q1-2018-earnings-mots.html.
Motus GI Company Profile
Motus GI Holdings, Inc is a medical technology company. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure.
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.